New depression pill shows promise in early trial
NCT ID NCT06235905
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This study tested an experimental drug called SPN-820 in 40 adults with major depressive disorder. The goal was to see if the drug safely reduces depression symptoms. Researchers measured changes in mood and daily function over time using standard depression rating scales.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Viking Clinical Research
Temecula, California, 92591, United States
Conditions
Explore the condition pages connected to this study.